AU2023219819B2 - Synthesis of antibacterial aminoglycoside analogs - Google Patents

Synthesis of antibacterial aminoglycoside analogs Download PDF

Info

Publication number
AU2023219819B2
AU2023219819B2 AU2023219819A AU2023219819A AU2023219819B2 AU 2023219819 B2 AU2023219819 B2 AU 2023219819B2 AU 2023219819 A AU2023219819 A AU 2023219819A AU 2023219819 A AU2023219819 A AU 2023219819A AU 2023219819 B2 AU2023219819 B2 AU 2023219819B2
Authority
AU
Australia
Prior art keywords
compound
formula
solvate
salt
tert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2023219819A
Other languages
English (en)
Other versions
AU2023219819A1 (en
Inventor
James Bradley Aggen
Michael Dappen
Adam Aaron Goldblum
Christopher E. Henry
Ricardo Filipe de Jesus Gonçalves MENDONÇA
João Carlos Falcão SARDINHA
Raissa TREND
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cipla USA Inc
Original Assignee
Cipla USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2018353156A external-priority patent/AU2018353156B2/en
Application filed by Cipla USA Inc filed Critical Cipla USA Inc
Priority to AU2023219819A priority Critical patent/AU2023219819B2/en
Publication of AU2023219819A1 publication Critical patent/AU2023219819A1/en
Application granted granted Critical
Publication of AU2023219819B2 publication Critical patent/AU2023219819B2/en
Priority to AU2025226793A priority patent/AU2025226793A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • C07H15/236—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2 a saccharide radical being substituted by an alkylamino radical in position 3 and by two substituents different from hydrogen in position 4, e.g. gentamicin complex, sisomicin, verdamycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2023219819A 2017-10-19 2023-08-22 Synthesis of antibacterial aminoglycoside analogs Active AU2023219819B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2023219819A AU2023219819B2 (en) 2017-10-19 2023-08-22 Synthesis of antibacterial aminoglycoside analogs
AU2025226793A AU2025226793A1 (en) 2017-10-19 2025-09-05 Synthesis of antibacterial aminoglycoside analogs

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762574544P 2017-10-19 2017-10-19
US62/574,544 2017-10-19
PCT/US2018/056536 WO2019079613A1 (en) 2017-10-19 2018-10-18 SYNTHESIS OF ANTIBACTERIAL AMINOGLYCOSIDE ANALOGUES
AU2018353156A AU2018353156B2 (en) 2017-10-19 2018-10-18 Synthesis of antibacterial aminoglycoside analogs
AU2023219819A AU2023219819B2 (en) 2017-10-19 2023-08-22 Synthesis of antibacterial aminoglycoside analogs

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2018353156A Division AU2018353156B2 (en) 2017-10-19 2018-10-18 Synthesis of antibacterial aminoglycoside analogs

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2025226793A Division AU2025226793A1 (en) 2017-10-19 2025-09-05 Synthesis of antibacterial aminoglycoside analogs

Publications (2)

Publication Number Publication Date
AU2023219819A1 AU2023219819A1 (en) 2023-09-07
AU2023219819B2 true AU2023219819B2 (en) 2025-06-05

Family

ID=64110232

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2023219819A Active AU2023219819B2 (en) 2017-10-19 2023-08-22 Synthesis of antibacterial aminoglycoside analogs
AU2025226793A Pending AU2025226793A1 (en) 2017-10-19 2025-09-05 Synthesis of antibacterial aminoglycoside analogs

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2025226793A Pending AU2025226793A1 (en) 2017-10-19 2025-09-05 Synthesis of antibacterial aminoglycoside analogs

Country Status (11)

Country Link
US (3) US11453658B2 (https=)
EP (1) EP3697797A1 (https=)
JP (3) JP7235741B2 (https=)
CN (1) CN111655709B (https=)
AR (1) AR113780A1 (https=)
AU (2) AU2023219819B2 (https=)
CA (1) CA3079508A1 (https=)
EA (1) EA202090980A1 (https=)
MX (1) MX2020003701A (https=)
TW (1) TWI801438B (https=)
WO (1) WO2019079613A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019079613A1 (en) * 2017-10-19 2019-04-25 Achaogen, Inc. SYNTHESIS OF ANTIBACTERIAL AMINOGLYCOSIDE ANALOGUES
CN110878108B (zh) * 2019-06-17 2022-11-11 山东安信制药有限公司 一种普拉佐米星的合成方法
CN110885350A (zh) * 2019-08-28 2020-03-17 山东安信制药有限公司 一种普拉佐米星的制备方法
CN110642907B (zh) * 2019-10-12 2020-11-06 上海博璞诺科技发展有限公司 普拉唑米星或其盐的合成方法
CN111116688B (zh) * 2020-01-07 2021-07-27 杭州华东医药集团新药研究院有限公司 普拉佐米星的制备方法
CN111205341A (zh) * 2020-02-17 2020-05-29 山东安信制药有限公司 一种普拉佐米星关键中间体的制备方法
CN112079882B (zh) * 2020-10-10 2021-10-08 山东安信制药有限公司 一种Plazomicin的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011143497A1 (en) * 2010-05-12 2011-11-17 Rempex Pharmaceuticals, Inc. Aminoglycoside derivatives

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4388233A (en) * 1981-05-15 1983-06-14 The Regents Of The University Of California Synthetic substrates for enzyme analysis
MX2009003909A (es) 2006-10-12 2009-05-25 Ptc Therapeutics Inc Métodos para dosificar un compuesto 1,2,4, - oxadiazol oralmente activo para el tratamiento de supresión de la mutación finalizadora.
US8614233B2 (en) * 2007-05-29 2013-12-24 Universite De Montreal Cinnamoyl inhibitors of transglutaminase
LT2217610T (lt) 2007-11-21 2017-02-27 Achaogen, Inc. Antibakteriniai aminoglikozidų analogai
EP2103602A1 (en) * 2008-03-17 2009-09-23 AEterna Zentaris GmbH Novel 1,2,4-triazole derivatives and process of manufacturing thereof
CA2761674C (en) * 2009-05-14 2016-11-29 Achaogen, Inc. Treatment of klebsiella pneumoniae infections with antibacterial aminoglycoside compounds
CA2761756A1 (en) * 2009-05-14 2010-11-18 Achaogen, Inc. Treatment of urinary tract infections with antibacterial aminoglycoside compounds
WO2010147836A1 (en) 2009-06-17 2010-12-23 Achaogen, Inc. Combination therapies using antibacterial aminoglycoside compounds
US9238670B2 (en) * 2013-03-15 2016-01-19 The Board Of Trustees Of The Leland Stanford Junior University Aminoglycoside antibiotics with reduced ototoxicity
WO2019079613A1 (en) * 2017-10-19 2019-04-25 Achaogen, Inc. SYNTHESIS OF ANTIBACTERIAL AMINOGLYCOSIDE ANALOGUES

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011143497A1 (en) * 2010-05-12 2011-11-17 Rempex Pharmaceuticals, Inc. Aminoglycoside derivatives

Also Published As

Publication number Publication date
AR113780A1 (es) 2020-06-10
CN111655709A (zh) 2020-09-11
US12122769B2 (en) 2024-10-22
US20250122177A1 (en) 2025-04-17
US20230074115A1 (en) 2023-03-09
AU2018353156A1 (en) 2020-05-07
EP3697797A1 (en) 2020-08-26
JP2025062009A (ja) 2025-04-11
MX2020003701A (es) 2020-07-22
EA202090980A1 (ru) 2020-10-07
CN111655709B (zh) 2024-01-02
JP2021500354A (ja) 2021-01-07
WO2019079613A1 (en) 2019-04-25
CA3079508A1 (en) 2019-04-25
US20200317652A1 (en) 2020-10-08
RU2020116171A (ru) 2021-11-19
AU2023219819A1 (en) 2023-09-07
BR112020007740A2 (pt) 2020-10-13
AU2025226793A1 (en) 2025-09-25
JP2023054316A (ja) 2023-04-13
TWI801438B (zh) 2023-05-11
JP7235741B2 (ja) 2023-03-08
US11453658B2 (en) 2022-09-27
TW201922233A (zh) 2019-06-16
RU2020116171A3 (https=) 2022-03-03

Similar Documents

Publication Publication Date Title
AU2023219819B2 (en) Synthesis of antibacterial aminoglycoside analogs
AU2016302697B2 (en) Processes for the preparation of GalNAc acid derivatives
US6642377B1 (en) Process for the preparation of basic antibiotic-inorganic acid addition salts and intermediate oxalates
EP0359172A1 (en) Azabicycloalkanes
US20080009637A1 (en) Preparation of N-protected-3-pyrrolidine-lactam substituted phosphonium salts
RU2798844C2 (ru) Синтез антибактериальных аминогликозидных аналогов
EP3074397B1 (en) A process for preparation of (2s, 5r)-7-oxo-n-[(2s)-pyrrolidin-2-yl-methyloxy]-6-(sulfooxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide
EA043984B1 (ru) Синтез антибактериальных аминогликозидных аналогов
BR122025029166A2 (pt) Processos para síntese de compostos análogos de aminoglicosídeos antibacterianos e os ditos compostos
HK40029080B (zh) 抗菌氨基糖苷类似物的合成
BR112020007740B1 (pt) Processos para síntese de compostos análogos de aminoglicosídeos antibacterianos e os ditos compostos
HK40029080A (en) Synthesis of antibacterial aminoglycoside analogs
EP3360865A1 (en) Process for the preparation of cyclopropyldiketopiperazines, and of a key intermediate of ds-5272
EP0094625B1 (en) Novel aminoglycosides and process for production thereof
CA2322424A1 (en) 5-imino-13-deoxy anthracycline derivatives, their uses, and processes for preparing them
JP2733511B2 (ja) 新規アミノアルカン誘導体
Sato et al. CHEMICAL MODIFICATION OF FORTIMICINS II. SELECTIVE PROTECTION OF FORTIMICINS A AND B
CN119350283A (zh) 一种普拉佐米星杂质h及其制备方法
AU2010277221A1 (en) Polymorphic form of olmesartan medoxomil
BR112017021926B1 (pt) Processo para a preparação de derivados de ácido galnac, sal de amina e processo para a preparação de conjugados de oligonucleotídeos galnac
HK1250717B (zh) 制备乙酰半乳糖胺酸衍生物的方法
HK1168837B (en) Tetracycline compounds
HK1168837A (en) Tetracycline compounds

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)